Concepedia

Pharmaceutical Batch Processing

Pharmaceutical Batch Processing is a systematic manufacturing approach within batch process systems in which a finite quantity of a pharmaceutical product is produced through a sequence of defined, validated, and documented steps that ensure quality, traceability, and compliance with regulatory standards, distinguishing it from continuous or general industrial batch processing by its adherence to stringent Good Manufacturing Practices (GMP) and patient-safety-critical quality controls.

79

Publications

4.1K

Citations

358

Authors

131

Institutions

Publications per year

2017–2026

27

Parents

Publications

79

Modernizing Pharmaceutical Manufacturing: from Batch to Continuous Production

Sau L. Lee, Thomas O’Connor, Xiaochuan Yang et al. · Journal of Pharmaceutical Innovation · 2015 · 853 citations · Full text

, , +14

Continuous Processing in the Manufacture of Active Pharmaceutical Ingredients and Finished Dosage Forms: An Industry Perspective

Peter Poechlauer, Julie B. Manley, Rinus Broxterman et al. · Organic Process Research & Development · 2012 · 176 citations

, , +17

Perspectives on the continuous manufacturing of powder‐based pharmaceutical processes

Marianthi Ierapetritou, Fernando J. Muzzio, Gintaras V. Reklaitis · AIChE Journal · 2016 · 156 citations

, , +14

A perspective on PSE in pharmaceutical process development and innovation

Krist V. Gernaey, Albert E. Cervera-Padrell, John M. Woodley · Computers & Chemical Engineering · 2012 · 145 citations

, , +12

Process analysis and optimization of continuous pharmaceutical manufacturing using flowsheet models

Zilong Wang, M. Sebastian Escotet‐Espinoza, Marianthi Ierapetritou · Computers & Chemical Engineering · 2017 · 119 citations

, , +16

1–5 of 79

Authors

358

  1. MI
    Marianthi Ierapetritou

    Rutgers, The State University of New Jersey, United States

    4 publications · 361 citations

    4

    h-index

  2. MK
    Markus Krumme

    Novartis (Switzerland), Switzerland

    3 publications · 195 citations

    3

    h-index

  3. TO
    Thomas O’Connor

    Center for Drug Evaluation and Research, United States

    3 publications · 929 citations

    3

    h-index

  4. SM
    Salvatore Mascia

    USV (India), India

    3 publications · 271 citations

    3

    h-index

  5. VP
    Victoria Pauli

    Heinrich Heine University Düsseldorf, Germany

    2 publications · 78 citations

    2

    h-index

1–5 of 358

Institutions

131

  1. Rutgers, The State University of New Jersey

    New Brunswick, United States

    6 h-index

    20 publications

    1K citations

  2. Eli Lilly (United States)

    Indianapolis, United States

    4 h-index

    22 publications

    1.4K citations

  3. Novartis (Switzerland)

    Basel, Switzerland

    4 h-index

    11 publications

    523 citations

  4. Pfizer (United States)

    New York, United States

    4 h-index

    12 publications

    458 citations

  5. Center for Drug Evaluation and Research

    Silver Spring, United States

    3 h-index

    26 publications

    8.4K citations

  6. Heinrich Heine University Düsseldorf

    Düsseldorf, Germany

    3 h-index

    6 publications

    442 citations

  7. Ghent University

    Ghent, Belgium

    3 h-index

    8 publications

    286 citations

  8. University of Lisbon

    Lisbon, Portugal

    2 h-index

    3 publications

    76 citations

1–8 of 131

Venues

  1. Computers & Chemical Engineering

    7 publications · 476 citations

    7

    h-index

  2. Organic Process Research & Development

    7 publications · 565 citations

    7

    h-index

  3. AIChE Journal

    5 publications · 353 citations

    5

    h-index

  4. International Journal of Pharmaceutics

    4 publications · 191 citations

    4

    h-index

  5. European Journal of Pharmaceutics and Biopharmaceutics

    EJPB · 3 publications · 275 citations

    3

    h-index

1–5